TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/26/25 20:46 | 8/22/25 | LAB | Standard Biotools Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Casdin Partners Master Fund, L.P. | NY | DT | 2 | P.m | 1,102 | 1.25 | 0 | 883 | 1 | 79,860 | I | |||||||||||||||
8/22/25 16:15 | 8/21/25 | AVTR | Avantor, Inc. | Electr | LabEq | Laboratory Analytical Instrum | Summe Gregory L | PA | D | 1 | P | 1,256 | 12.56 | 0 | 100 | 63 | 258 | I | ||||||||||||||||
6/13/25 16:39 | 6/12/25 | QTRX | Quanterix Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Walt David R | MA | D | 2 | P.m | 2,119 | 5.73 | 0 | 370 | 25 | 1,867 | D | |||||||||||||||
6/10/25 16:08 | 6/9/25 | QTRX | Quanterix Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Toloue Masoud | MA | DO | P,CEO | 1 | P | 249 | 5.42 | 0 | 46 | 10 | 519 | D | ||||||||||||||
6/9/25 17:10 | 6/6/25 | QTRX | Quanterix Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Donnelly William P | MA | D | 1 | P | 506 | 5.44 | 0 | 93 | 203 | 139 | D | |||||||||||||||
6/9/25 16:15 | 6/6/25 | BRKR | Bruker Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Laukien Frank H | MA | DOT | P,CEO | 1 | P | 100 | 38.36 | 0 | 3 | 0 | 40,457 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |